News

A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...
AbbVie's dividends add to its attractiveness at an uncertain time, adding to robust price returns over time. Click here to ...
ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.
AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...
AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to buy now. On July 10, Morgan Stanley analyst ...
The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.
Subclinical synovitis is significantly more common among patients with psoriasis without musculoskeletal involvement than ...
This was the stock's second consecutive day of losses.
A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.
AbbVie employees in Asia participated in the tenth Week of Possibilities (WOP), the AbbVie Foundation's annual global ...
AbbVie Inc. (NYSE: ABBV) is one of the high-margin pharma stocks to buy now . AbbVie Inc. (NYSE:ABBV) received a slight boost ...
Skyrizi came out with the largest Q2 impressions share of voice (SOV) spot for over-the-counter (OTC) pharma and Rx brands for the second year in a row, according to iSpot.tv data released this week.